These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19750226)

  • 1. Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons.
    Diaz-Ruiz O; Zapata A; Shan L; Zhang Y; Tomac AC; Malik N; de la Cruz F; Bäckman CM
    PLoS One; 2009 Sep; 4(9):e7027. PubMed ID: 19750226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.
    Domanskyi A; Geissler C; Vinnikov IA; Alter H; Schober A; Vogt MA; Gass P; Parlato R; Schütz G
    FASEB J; 2011 Sep; 25(9):2898-910. PubMed ID: 21593433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor PTEN regulates motor responses to striatal dopamine in normal and Parkinsonian animals.
    Stavarache MA; Musatov S; McGill M; Vernov M; Kaplitt MG
    Neurobiol Dis; 2015 Oct; 82():487-494. PubMed ID: 26232589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
    Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal KIF5b deletion induces striatum-dependent locomotor impairments and defects in membrane presentation of dopamine D2 receptors.
    Cromberg LE; Saez TMM; Otero MG; Tomasella E; Alloatti M; Damianich A; Pozo Devoto V; Ferrario J; Gelman D; Rubinstein M; Falzone TL
    J Neurochem; 2019 May; 149(3):362-380. PubMed ID: 30664247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
    Chritin M; Blanchard V; Raisman-Vozari R; Feuerstein C; Agid Y; Javoy-Agid F; Savasta M
    Eur J Neurosci; 1996 Dec; 8(12):2511-20. PubMed ID: 8996800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of GPR52 enhances the locomotor-stimulating effect of an adenosine A
    Nishiyama K; Suzuki H; Maruyama M; Yoshihara T; Ohta H
    Brain Res; 2017 Sep; 1670():24-31. PubMed ID: 28583861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors.
    Cortés M; Malave L; Castello J; Flajolet M; Cenci MA; Friedman E; Rebholz H
    J Neurosci; 2017 Dec; 37(49):11930-11946. PubMed ID: 29097596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
    Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
    Gross CE; Ravenscroft P; Dovero S; Jaber M; Bioulac B; Bezard E
    J Neurochem; 2003 Mar; 84(6):1246-55. PubMed ID: 12614325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal Distribution and Cytoarchitecture of Dopamine Receptor Subtype 1 and 2: Evidence from Double-Labeling Transgenic Mice.
    Ren K; Guo B; Dai C; Yao H; Sun T; Liu X; Bai Z; Wang W; Wu S
    Front Neural Circuits; 2017; 11():57. PubMed ID: 28860974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE; Wooten GF
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular Profiles of Prodynorphin and Preproenkephalin mRNA-Expressing Neurons in the Anterior Olfactory Tubercle of Mice.
    Maegawa A; Murata K; Kuroda K; Fujieda S; Fukazawa Y
    Front Neural Circuits; 2022; 16():908964. PubMed ID: 35937204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons.
    Rapanelli M; Frick LR; Horn KD; Schwarcz RC; Pogorelov V; Nairn AC; Pittenger C
    J Biol Chem; 2016 Sep; 291(40):21042-21052. PubMed ID: 27510032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice.
    Zhang Y; Granholm AC; Huh K; Shan L; Diaz-Ruiz O; Malik N; Olson L; Hoffer BJ; Lupica CR; Hoffman AF; Bäckman CM
    Brain; 2012 Sep; 135(Pt 9):2736-49. PubMed ID: 22961549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
    Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
    Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons.
    Baydyuk M; Russell T; Liao GY; Zang K; An JJ; Reichardt LF; Xu B
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1669-74. PubMed ID: 21205893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.
    Surmeier DJ; Ding J; Day M; Wang Z; Shen W
    Trends Neurosci; 2007 May; 30(5):228-35. PubMed ID: 17408758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.